Back
Speaker illustration

Doctor Mohamed Abouzid

Poznan University of Medical Sciences, Poznan (Poland)

Mohamed Abouzid, B.Pharm, MClinPharm, PharmD is a PhD Fellow at Poznan University of Medical Sciences. His research interests include pharmacokinetics, bioanalysis, therapeutic drug monitoring, and public health. As for his academic background, he holds degrees of a Doctor of Pharmacy and Master of Pharmacy from Poznan University of Medical Sciences (PUMS). He received the University and the President Awards from PUMS. He completed clinical rotations at the University of Kentucky, and was a research visitor to Maryland University and Samara Medical University. He was also an ORBIS Secondee to Rutgers University, School of Pharmacy. Mohamed now has over 25 publications with an h-index of 10.

Presentations Articles

Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials

Event: ESC Congress 2024

Topic: Anticoagulants

Session: Novel anticoagulants and indications

Access
Like
Thumbnail

A meta-analysis of the efficacy and safety of exercise-based cardiac rehabilitation in patients with left ventricular assist devices.

Event: ESC Congress 2024

Topic: Ventricular Assist Devices

Session: Devices in heart failure: new findings

Access
Like
Thumbnail

The efficacy and safety of GLP-1 agonists to modify cardiovascular morbidity in patients with obesity without diabetes mellitus: a meta-analysis involving 32,884 patients

Event: ESC Congress 2024

Topic: Cardiovascular Pharmacotherapy

Session: Real-world evidence on the cardiovascular effects of therapies for diabetes

Access
Like
Thumbnail

Mild hypercapnia versus normocapnia in resuscitated out-of-hospital cardiac arrest patients: a systematic review and meta-analysis.

Event: ESC Congress 2024

Topic: Cardiac Arrest

Session: Innovations in cardiac arrest

Access
Like
Thumbnail

Efficacy and safety of intravenous iron therapy in heart failure patients with iron deficiency: a systematic review and meta-analysis of randomized controlled trials

Event: ESC Congress 2024

Topic: Cardiovascular Pharmacotherapy

Session: Novel and old treatments, evidence in large populations

Access
Like
Thumbnail

Intermittent levosimendan infusions for advanced heart failure: a systematic review and meta-analysis of randomized controlled trials.

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Phenotypic approach in heart failure therapy

Access
Like
Thumbnail

Efficacy and safety of of SGLT2 ihibtors in post mi patients: a systematic review and meta-analysis of RCTs

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (1)

Access
Like
Thumbnail

Rotational atherectomy versus orbital atherectomy for the treatment of calcified coronary lesions: a systematic review and meta-analysis of 81,873 patients

Event: ESC Congress 2024

Topic: Percutaneous Coronary Intervention (PCI)

Session: Calcium modification: optimising complexities in percutaneous coronary intervention

Access
Like
Thumbnail

Ultrasound-guided versus palpation-guided techniques for vessel catheterization in children undergoing cardiac surgery. A systematic review and meta-analysis of randomized controlled trials.

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Special Populations: Paediatric Cardiology

Session: Cardiovascular disease in pregnancy and childhood

Access
Like
Thumbnail

Sheathless versus standard guiding catheters for transradial percutaneous coronary interventions: a systematic review and meta-analysis

Event: ESC Congress 2024

Topic: Primary Percutaneous Coronary Intervention (PCI)

Session: Tips, tricks, techniques, and technologies in radial angiography

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources